Computational Advances in Drug Discovery (G1)
May 7-10, 2026  | Park Plaza Riverbank London, London, United Kingdom
Karen Akinsanya, Alexander Hillisch, Najat Khan and Gang Liu
Scholarship Deadline: Feb. 11, 2026 | Abstract Deadline: Apr. 16, 2026 | Early Registration Deadline: Mar. 11, 2026
* Session Chair † Invited but not yet accepted | Program current as of February 25, 2026 1 AM | For the most up-to-date details, visit https://www.keystonesymposia.org
Thursday, May 7, 2026
4:00–8:00 PM Registration
6:00–8:00 PM Welcome Mixer
Friday, May 8, 2026
7:30–8:30 AM Breakfast Individual Hotel
8:00–8:30 AM Poster Setup
8:15–5:00 PM Poster Viewing
8:30–8:40 AM Welcome Remarks
8:40–9:30 AM Keynote Address
  Simon Richards, Isomorphic Labs
Development and Application of an AI-First Drug Design Platform at Isomorphic Labs
 
9:30–11:45 AM Computation Methods in Structure-Based Small Molecule Design
  Christina Schindler, Merck KGaA
Computational Drug Design across Different Modalities
 
  Richard Bonneau, Genentech
Avoiding Funnels: Using Active Learning and Generative AI to Drive Drug Discovery
 
  Heidi Koldsoe, Antares Therapeutics
Drugging the Undruggable: Leveraging Computational Techniques to Drive Compound Design
 
  Short Talk(s) Chosen from Abstracts
 
10:00–10:20 AM Coffee Break
11:45–12:45 PM Lunch
12:30–2:30 PM Poster Session 1
2:30–4:30 PM Symposia Spotlight
  Short Talk(s) Chosen from Abstracts
 
4:30–5:00 PM Coffee Available
5:00–7:00 PM Computational Methods in Protein Therapeutic Design
  Christian Stegmann, EvlaBio
Harnessing Generative AI to Creation and Development of ABS-201: A Novel Anti-PRLR Antibody for Androgenic Alopecia
 
  Bingxu Liu, University of Washington
Peptide-MHCI (pMHCI) Binder Design
 
  Sebastian Kelm, UCB Pharma
in silico Antibody Design
 
  Short Talk(s) Chosen from Abstracts
 
7:00–8:00 PM On Own for Dinner
Saturday, May 9, 2026
7:30–8:30 AM Breakfast Individual Hotel
8:30–11:30 AM AI-based Acceleration of Multi-Omics Advances in Cell Biology
  Daniel J. Anderson, Eikon Therapeutics
Single Molecule Tracking in Drug Discovery and Systems Biology
 
  Alexander Hillisch, UCB BioSciences GmbH
Holistic De Novo Drug Design at UCB
 
  Ben Lehner, Wellcome Sanger Institute
Complete Allosteric Maps for Drug Discovery
 
  Short Talk(s) Chosen from Abstracts
 
9:30–9:50 AM Coffee Break
9:50–9:55 AM Award Recipient Acknowledgement
11:00–1:00 PM Poster Setup
11:30–12:30 PM Lunch
12:30–2:30 PM Poster Session 2
1:00–10:00 PM Poster Viewing
3:30–4:30 PM Career Roundtable
4:30–5:00 PM Coffee Available
5:00–7:00 PM Advances in Predictive Toxicology Methods
  Blanca Rodriguez, University of Oxford
Digital Twins and In Silico Clinical Trials for Drug Discovery
 
  Friedemann Schmidt, Sanofi
Decoding Toxicology: Computational Frameworks for Next-Generation Predictive Safety
 
  Henrik Renner, Evotec SE
Human iPSC High-throughput Screening for Teratogenicity Hazard Identification
 
  Short Talk(s) Chosen from Abstracts
 
7:00–8:00 PM On Own for Dinner
Sunday, May 10, 2026
7:30–8:30 AM Breakfast Individual Hotel
8:30–11:30 AM Machine Learning Applications in Translational Science
  Tali Raveh-Sadka, Immunai
Identification of High Confidence Candidate Markers for Macrophage Infiltrating Tumor Microenvironment Through Single Cell Genomic Atlases
 
  Bissan Al-Lazikani, University of Texas MD Anderson Cancer Center
The Kinase Polypharmacology Landscape of Clinical PARP Inhibitors
 
  Gayle Wittenberg, Janssen R&D, LLC
A Multimodal Digital Biomarker of Functional Deficits in Early‐Stage Alzheimer’s Disease
 
  Short Talk(s) Chosen from Abstracts
 
9:30–9:50 AM Coffee Break
11:30–12:30 PM Lunch
2:30–4:30 PM Panel: Opportunities and Challenges in Computational Drug Discovery and Development?
  * Karen Akinsanya, Schrödinger
 
  Najat Khan, Recursion Pharmaceuticals
 
  Alexander Hillisch, UCB BioSciences GmbH
 
  Richard Bonneau, Genentech
 
  Sharon Benzeno, Adaptive Biotechnologies
 
4:30–5:00 PM Coffee Available
5:00–6:45 PM AI Application in Global Health Drug Discovery
  Jonathan E Gable, Novartis Biomedical Research
Diverse Application of AI in Drug Discovery at Novartis
 
  Jinjiang Guo, Global Health Drug Discovery Institute
Generative AI-Enabled Multi-Parameter Lead Optimization in Early Drug Discovery
 
  Short Talks Chosen from Abstracts
 
6:45–7:00 PM Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
7:00–8:00 PM On Own for Dinner
Monday, May 11, 2026
12:00–11:59 PM Departure